The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
